Kinfo
Novartis AG Sponsored ADR logo

Novartis AG Sponsored ADR

NVSNYSEHealthcare·US · USD
$140.93
-0.07 (-0.05%)
Prices as of October 5, 2026 · market closed

Price

Key statistics

Valuation
Market cap267.87B USD
Enterprise value309.80B USD
Trailing P/E21.30
Forward P/E14.33
PEG ratio-1.22
Price / sales4.73
Price / book6.45
Profitability
Gross margin75.19%
Operating margin34.62%
Profit margin22.50%
Return on assets10.25%
Return on equity30.35%
Income (TTM)
Revenue56.69B USD
Gross profit42.51B USD
EBITDA22.45B USD
Net income12.76B USD
Diluted EPS$6.62
Rev. growth (YoY)0.80%
Balance sheet
Total cash7.62B USD
Total debt49.01B USD
Debt / equity116.85
Current ratio0.86
Book value / share$21.86
Cash flow (TTM)
Operating cash flow18.39B USD
Levered free cash flow11.90B USD
Shares & price
Shares outstanding1.90B
Float1.86B
Held by institutions7.27%
Beta0.49
50-day MA$150.52
200-day MA$150.73
52-week high$170.46
52-week low$121.57
Dividends
Forward rate
$19.09
Yield
13.55%
Payout ratio
71.60%
Frequency
Annual
Recent payments
  • 2026-03-11$4.77
Earnings (EPS)
DateEst.ActualSurprise2026-07-212.152.41+12.09%2026-04-282.071.99−3.86%2026-03-30-0.65-0.68−4.62%2026-02-042.002.03+1.50%
About Novartis AG Sponsored ADR

Novartis AG Sponsored ADR represents Novartis AG, a global healthcare company focused on developing, manufacturing, and commercializing prescription medicines and related healthcare products. Novartis serves major therapeutic areas including oncology, immunology, cardiovascular, neuroscience, and ophthalmology, with a portfolio built around innovative treatments for serious and chronic diseases. The company operates across research, development, production, and global distribution, supporting hospitals, physicians, and patients in markets worldwide. Novartis also includes medicines and platforms designed to improve access, formulation, and delivery of therapies, making it a significant participant in the pharmaceutical industry and the broader healthcare market. As a sponsored ADR, it provides U.S. investors with access to Novartis shares through an American depositary receipt structure.

Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
75,883
Headquarters
Basel, Switzerland

Frequently asked questions about Novartis AG Sponsored ADR